BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 26829552)

  • 1. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice.
    Jiang Y; Zhu R; Luo L; Mu Q; Zhu Y; Luo H; Zou X; Shen X
    Intervirology; 2015; 58(6):343-9. PubMed ID: 26829552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
    Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
    Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
    Zhou L; He X; Gao B; Xiong S
    J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxymatrine provides protection against Coxsackievirus B3-induced myocarditis in BALB/c mice.
    Jiang Y; Zhu Y; Mu Q; Luo H; Zhi Y; Shen X
    Antiviral Res; 2017 May; 141():133-139. PubMed ID: 28115196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury.
    Dörner A; Grunert HP; Lindig V; Chandrasekharan K; Fechner H; Knowlton KU; Isik A; Pauschinger M; Zeichhardt H; Schultheiss HP
    J Mol Med (Berl); 2006 Oct; 84(10):842-51. PubMed ID: 16924471
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
    J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of 20(s)-protopanaxtriol on viral myocarditis infected by coxsackievirus B3.
    Wang X; Wang Y; Ren Z; Qian C; Li Y; Wang Q; Zhang Y; Zheng L; Jiang J; Yang C; Wang D; Zhang Y; Fan J; Wang Y
    Pathobiology; 2012; 79(6):285-9. PubMed ID: 22688124
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Fu Q; Gao L; Fu X; Meng Q; Lu Z
    J Microbiol Biotechnol; 2019 Aug; 29(8):1230-1239. PubMed ID: 31370111
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
    Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.
    Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M
    Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma.
    Zhang Y; Zhu H; Huang C; Cui X; Gao Y; Huang Y; Gong W; Zhao Y; Guo S
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):190-5. PubMed ID: 16495755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
    Stein EA; Pinkert S; Becher PM; Geisler A; Zeichhardt H; Klopfleisch R; Poller W; Tschöpe C; Lassner D; Fechner H; Kurreck J
    J Infect Dis; 2015 Feb; 211(4):613-22. PubMed ID: 25193982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
    Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
    Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis.
    Wang YF; Wang XY; Ren Z; Qian CW; Li YC; Kaio K; Wang QD; Zhang Y; Zheng LY; Jiang JH; Yang CR; Liu Q; Zhang YJ; Wang YF
    Antiviral Res; 2009 Nov; 84(2):150-8. PubMed ID: 19699238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine impairs coxsackievirus B3-induced myocarditis through the inhibition of virus replication and host pro-inflammatory response.
    Dai Q; He X; Yu H; Bai Y; Jiang L; Sheng H; Peng J; Wang M; Yu J; Zhang K
    J Med Virol; 2021 Jun; 93(6):3581-3589. PubMed ID: 33336842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis.
    Dai K; Wang Y; Tai S; Ni H; Lian H; Yu Y; Liao W; Zheng C; Chen Q; Kuver A; Li J
    Cardiovasc Ther; 2018 Dec; 36(6):e12477. PubMed ID: 30380183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.
    Yun SH; Lee WG; Kim YC; Ju ES; Lim BK; Choi JO; Kim DK; Jeon ES
    J Infect Dis; 2012 Feb; 205(3):491-7. PubMed ID: 22207647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
    Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
    Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a C-type CpG ODN on CVB3-infected mice].
    Yang L; Sun WQ; Wang L; Wang XL; Wan M; Yu YL; Wang LY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Feb; 25(2):115-7. PubMed ID: 19174007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caboxamycin Inhibits Heart Inflammation in a Coxsackievirus B3-Induced Myocarditis Mouse Model.
    Kim HG; Hillman PF; Lee YJ; Jeon HE; Lim BK; Nam SJ
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.